Cartesian Therapeutics, Inc. Fair Value Adjustment of Warrants
Cartesian Therapeutics, Inc. (RNAC) reported Fair Value Adjustment of Warrants of $118.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-06
- Cartesian Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was $118.00K.
- Cartesian Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was -$94.00K.
- Cartesian Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$707.00K, a 388.57% decline year-over-year.
- Cartesian Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$516.00K.
- Cartesian Therapeutics, Inc. fair value adjustment of warrants for fiscal 2025 was -$3.69M.
- Cartesian Therapeutics, Inc. fair value adjustment of warrants for fiscal 2024 was -$2.56M.
- Cartesian Therapeutics, Inc. fair value adjustment of warrants for fiscal 2023 was -$12.75M.
- Cartesian Therapeutics, Inc. fair value adjustment of warrants for fiscal 2022 was -$20.88M, a 992.77% decline from fiscal 2021.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | $118.00K 10-Q · filed 2026-08-06 | $24.00K 10-Q · filed 2026-08-06 | -$683.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$94.00K 10-Q · filed 2026-04-30 | -$801.00K derived: sum of 2 quarters · filed 2026-04-30 | -$1.32M derived: sum of 3 quarters · filed 2026-04-30 | -$1.97M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$707.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$1.22M derived: sum of 2 quarters · filed 2026-03-09 | -$1.88M derived: sum of 3 quarters · filed 2026-08-06 | -$3.69M 10-K · filed 2026-03-09 |
| 2025-09-30 | -$516.00K 10-Q · filed 2025-11-06 | -$1.17M derived: sum of 2 quarters · filed 2026-08-06 | -$2.99M 10-Q · filed 2025-11-06 | -$2.74M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$654.00K 10-Q · filed 2026-08-06 | -$2.47M 10-Q · filed 2026-08-06 | -$2.23M derived: sum of 3 quarters · filed 2026-08-06 | -$7.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.82M 10-Q · filed 2026-04-30 | -$1.57M derived: sum of 2 quarters · filed 2026-04-30 | -$7.24M derived: sum of 3 quarters · filed 2026-04-30 | -$3.33M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$5.42M derived: sum of 2 quarters · filed 2026-03-09 | -$1.52M derived: sum of 3 quarters · filed 2026-03-09 | -$2.56M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$5.67M 10-Q · filed 2025-11-06 | -$1.76M derived: sum of 2 quarters · filed 2025-11-06 | -$2.80M 10-Q · filed 2025-11-06 | -$9.50M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $3.91M 10-Q · filed 2025-08-07 | $2.87M 10-Q · filed 2025-08-07 | -$3.83M derived: sum of 3 quarters · filed 2025-08-07 | -$7.62M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$1.04M 10-Q · filed 2025-05-08 | -$7.74M derived: sum of 2 quarters · filed 2025-05-08 | -$11.53M derived: sum of 3 quarters · filed 2025-05-08 | -$17.87M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$10.48M derived: sum of 2 quarters · filed 2025-03-13 | -$16.82M derived: sum of 3 quarters · filed 2025-03-13 | -$12.75M 10-K · filed 2025-03-13 |
| 2023-09-30 | -$3.79M 10-Q · filed 2024-11-07 | -$10.13M derived: sum of 2 quarters · filed 2024-11-07 | -$6.05M 10-Q · filed 2024-11-07 | -$19.60M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$6.34M 10-Q · filed 2024-08-08 | -$2.26M 10-Q · filed 2024-08-08 | -$15.81M derived: sum of 3 quarters · filed 2024-08-08 | -$9.28M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $4.08M 10-Q · filed 2024-05-08 | -$9.47M derived: sum of 2 quarters · filed 2024-05-08 | -$2.94M derived: sum of 3 quarters · filed 2024-05-08 | $1.71M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$13.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$7.01M derived: sum of 2 quarters · filed 2024-03-07 | -$2.37M derived: sum of 3 quarters · filed 2024-03-07 | -$20.88M 10-K · filed 2024-03-07 |
| 2022-09-30 | $6.54M 10-Q · filed 2023-11-13 | $11.19M derived: sum of 2 quarters · filed 2023-11-13 | -$7.33M 10-Q · filed 2023-11-13 | -$16.32M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $4.65M 10-Q · filed 2023-08-17 | -$13.87M 10-Q · filed 2023-08-17 | -$22.86M derived: sum of 3 quarters · filed 2024-03-07 | -$23.46M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | -$18.52M 10-Q · filed 2023-05-04 | -$27.51M derived: sum of 2 quarters · filed 2024-03-07 | -$28.10M derived: sum of 3 quarters · filed 2024-03-07 | -$32.92M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$9.59M derived: sum of 2 quarters · filed 2024-03-07 | -$14.41M derived: sum of 3 quarters · filed 2024-03-07 | $2.34M 10-K · filed 2024-03-07 |
| 2021-09-30 | -$592.00K 10-Q · filed 2022-11-03 | -$5.41M derived: sum of 2 quarters · filed 2022-11-03 | $11.34M 10-Q · filed 2022-11-03 | $18.17M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | -$4.82M 10-Q · filed 2022-08-08 | $11.93M 10-Q · filed 2022-08-08 | $18.76M derived: sum of 3 quarters · filed 2023-03-02 | $13.98M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $16.75M 10-Q · filed 2022-05-05 | $23.58M derived: sum of 2 quarters · filed 2023-03-02 | $18.80M derived: sum of 3 quarters · filed 2023-03-02 | $26.34M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $6.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $2.06M derived: sum of 2 quarters · filed 2023-03-02 | $9.60M derived: sum of 3 quarters · filed 2023-03-02 | $10.44M 10-K · filed 2023-03-02 |
| 2020-09-30 | -$4.78M 10-Q · filed 2021-11-09 | $2.76M derived: sum of 2 quarters · filed 2021-11-09 | $3.61M 10-Q · filed 2021-11-09 | $4.46M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $7.54M 10-Q · filed 2021-08-12 | $8.38M 10-Q · filed 2021-08-12 | $9.24M derived: sum of 3 quarters · filed 2022-03-10 | $9.24M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | $846.00K 10-Q · filed 2021-05-13 | $1.70M derived: sum of 2 quarters · filed 2022-03-10 | $1.70M derived: sum of 3 quarters · filed 2022-03-10 | $1.70M derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $857.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $857.00K derived: sum of 2 quarters · filed 2022-03-10 | $857.00K derived: sum of 3 quarters · filed 2022-03-10 | $857.00K 10-K · filed 2022-03-10 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-12 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $0.00 derived: sum of 3 quarters · filed 2020-03-12 | $0.00 10-K · filed 2020-03-12 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | $0.00 derived: sum of 3 quarters · filed 2019-03-15 | $0.00 derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-11 | $0.00 derived: sum of 2 quarters · filed 2019-03-15 | $0.00 derived: sum of 3 quarters · filed 2019-03-15 | -$8.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $0.00 derived: sum of 2 quarters · filed 2019-03-15 | -$8.00K derived: sum of 3 quarters · filed 2019-03-15 | $12.00K 10-K · filed 2019-03-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$8.00K derived: sum of 2 quarters · filed 2017-11-07 | $12.00K 10-Q · filed 2017-11-07 | -$54.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $12.00K 10-Q · filed 2017-08-11 | -$54.00K derived: sum of 3 quarters · filed 2018-03-15 | |
| 2016-03-31 | $20.00K 10-Q · filed 2017-05-11 | -$46.00K derived: sum of 2 quarters · filed 2018-03-15 | ||
| 2015-12-31 | -$66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$83.00K 10-K · filed 2018-03-15 | ||
| 2015-09-30 | -$17.00K 10-Q · filed 2016-11-10 | |||
| 2014-12-31 | $38.00K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |